Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial
if (g_displayableSlots.mobileTopLeaderboard) {
pushDisplayAd(function() { googletag.display('div-gpt-mobile-top-leaderboard'); });
}
National Institutes of HealthMar 12 2025
NIH-sponsored trial data offer…
Read More...
Read More...